Account Executive - Core Lab - LA/MS
AbbottFull Time
Junior (1 to 2 years)
Candidates must possess a strong understanding of molecular diagnostics for oncology and the evolving competitive landscape, with excellent knowledge of oncology, hematology, chemotherapeutics, and targeted agents. Proficiency in Microsoft Office Suite, particularly Excel and PowerPoint, and regular utilization of Salesforce.com are essential. The role requires advanced presentation skills, business acumen, problem-solving abilities, and strong administrative skills to manage business in complex environments. Candidates should demonstrate Tempus’ Values by acting with integrity, respect, and trust, and must be comfortable selling at the executive level. A keen understanding of the payor and reimbursement environment in oncology and diagnostics is also required. Frequent travel (over 50%) throughout the territory is necessary.
The Clinical Account Executive will drive strategic business expansion and collaboration opportunities with major U.S. cancer centers, clinics, top oncology practices, Key Opinion Leaders, and Academic Medical Centers within the assigned territory. Responsibilities include structuring detailed strategic plans for client acquisition and retention, maximizing client-bill contracting opportunities, and implementing laboratory services agreements. The role involves collaborating with sales positions to achieve company goals, identifying and developing partnering opportunities, and promoting compliance with new web-based molecular information tools. Additionally, the executive will analyze the competitive landscape, monitor sales performance, develop and implement a comprehensive territory business plan, and work effectively with individuals across multiple departments. Embracing and representing the Tempus company culture is also a key responsibility.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.